机构:[1]Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing 100021, China[2]Fourth Hospital of Hebei Medical University, Shijiazhuang 050000, China河北医科大学第四医院[3]Tianjin Medical University Cancer Institute & Hospital, Tianjin 300070, China[4]Shenzhen People’s Hospital, Shenzhen 518020, China深圳市人民医院深圳医学信息中心[5]The Second Military Medical University Changhai Hospital, Shanghai 200433, China[6]Fudan University Zhongshan Hospital, Shanghai 200032, China[7]Jiangsu Cancer Hospital, Nanjing 210009, China[8]The 307th Hospital of Chinese People’s Liberation Army, Beijing 100071, China[9]Chinese People’s Liberation Army General Hospital, Beijing 100853, China[10]Beijing Cancer Hospital, Beijing 100142, China[11]Jiangsu Province Hospital, Nanjing 210029, China江苏省人民医院[12]Qinghai University Affiliated Hospital, Xining 810000, China[13]The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510000, China[14]Zhejiang Cancer Hospital, Hangzhou 310022, China浙江省肿瘤医院[15]Beijing Chest Hospital, Capital Medical University, Beijing 101149, China[16]Harbin Medical University Cancer Hospital, Harbin 150081, China[17]The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China[18]Nanfang Medical University Nanfang Hospital, Guangzhou 510515, China[19]Tongji University Affiliated Shanghai Pulmonary Hospital, Shanghai 200433, China[20]The First Affiliated Hospital, Zhejiang University, Hangzhou 310003, China浙江大学医学院附属第一医院[21]Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai 200030, China[22]Changzhou Fourth People’s Hospital, Changzhou 213001, China[23]Fujian Cancer Hospital, Fuzhou 350014, China
第一作者机构:[1]Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing 100021, China[*1]Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing 100021, China
通讯作者:
通讯机构:[1]Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing 100021, China[*1]Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing 100021, China
推荐引用方式(GB/T 7714):
Yuankai Shi,Yan Sun,Cuimin Ding,et al.China experts consensus on icotinib for non-small cell lung cancer treatment (2015 version)[J].ANNALS OF TRANSLATIONAL MEDICINE.2015,3(18):doi:10.3978/j.issn.2305-5839.2015.10.30.
APA:
Yuankai Shi,Yan Sun,Cuimin Ding,Ziping Wang,Changli Wang...&Hong Jiao.(2015).China experts consensus on icotinib for non-small cell lung cancer treatment (2015 version).ANNALS OF TRANSLATIONAL MEDICINE,3,(18)
MLA:
Yuankai Shi,et al."China experts consensus on icotinib for non-small cell lung cancer treatment (2015 version)".ANNALS OF TRANSLATIONAL MEDICINE 3..18(2015)